Background: Cutaneous metastases can occur in a wide variety of internal malignancies and may be the first sign of a clinically silent visceral cancer. Study Design: A retrospective analysis was made of 138 cases diagnosed with cutaneous and subcutaneous metastasis on fine-needle aspiration cytology (FNAC). Primary tumors of the skin/subcutis were excluded. Results: Of 138 cases, the primary was known in 101 cases and unknown in 37 cases. The age of the patients ranged from 5 to 86 years, and 76 (55.1%) were male and 62 (44.9%) were female. Clinically, the most common lesion was a single nodule (n = 77, 55.8%). The chest wall was the predominant site (n = 53, 38.4%). In males and females, the most common primary sites were the lung (n = 16) and breast (n = 24), respectively. On cytology, the most common diagnosis was metastatic adenocarcinoma (n = 41, 29.7%). Of 37 cases with an unknown primary, FNAC helped to locate the primary site in 17 (45.9%) cases, while in 20 cases it remained undiagnosed. Conclusions: FNAC is a rapid and safe technique that can be used as a first line of investigation for confirmation of metastatic lesions of the skin. Critical evaluation of cytomorphological features along with relevant clinical details could help in the localization of an unknown primary site in some cases.

Journal Section:
Editor's choice
Keywords:
Metastasis, Cutaneous, Skin, Cytomorphology, Fine-needle aspiration cytology
1.
Alcaraz I, Cerroni L, Rütten A, Kutzner H, Requena L: Cutaneous metastases from internal malignancies: a clinicopathologic and immunohistochemical review. Am J Dermatopathol 2012;34:347-393.
2.
Bansal R, Patel T, Sarin J, Parikh B, Ohri A, Trivedi P: Cutaneous and subcutaneous metastases from internal malignancies: an analysis of cases diagnosed by fine needle aspiration. Diagn Cytopathol 2011;39:882-887.
3.
Rolz-Cruz G, Kim CC: Tumor invasion of the skin. Dermatol Clin 2008;26:89-102.
4.
El Khoury J, Khalifeh I, Kibbi AG, Abbas O: Cutaneous metastasis: clinicopathological study of 72 patients from a tertiary care center in Lebanon. Int J Dermatol 2014;53:147-158.
5.
Hussein MR: Skin metastasis: a pathologist's perspective. J Cutan Pathol 2010;37:e1-e20.
6.
Aldret S, Cotton L: Skin as a site of metastasis. Osteopath Fam Phys 2012;4:13-17.
7.
Schoenlaub P, Sarraux A, Grosshans E, Heid E, Cribier B: Survival after cutaneous metastasis: a study of 200 cases. Ann Dermatol Venereol 2001;128:1310-1315.
8.
Handa U, Garg S, Mohan H: Fine-needle aspiration cytology of Sister Mary Joseph's (paraumbilical) nodules. Diagn Cytopathol 2008;36:348-350.
9.
Leonard N: Cutaneous metastases: where do they come from and what can they mimic? Curr Diagn Pathol 2007;13:320-330.
10.
Fernández-Antón Martínez MC, Parra-Blanco V, Avilés Izquierdo JA, Suárez Fernández RM: Cutaneous metastases of internal tumors. Actas Dermosifiliogr 2013;104:841-853.
11.
Wollina U, Graefe T, Konrad H, Schönlebe J, Koch A, Hansel G: Cutaneous metastases of internal cancer. Acta Dermatoven APA 2004;3:79-84.
12.
Pak HY, Foster BA, Yokota SB: The significance of cutaneous metastasis from visceral tumors diagnosed by fine-needle aspiration biopsy. Diagn Cytopathol 1987;3:24-29.
13.
Avgerinou G, Flessas I, Hatziolou E, Zografos G, Nitsios I, Zagouri F: Cutaneous metastasis of signet-ring gastric adenocarcinoma to the breast with unusual clinicopathological features. Anticancer Res 2011;31:2373-2378.
14.
Hu SC, Chen GS, Wu CS, Chai CY, Chen WT, Lan CC: Rates of cutaneous metastases from different internal malignancies: experience from a Taiwanese medical center. J Am Acad Dermatol 2009;60:379-387.
15.
Saeed S, Keehn CA, Morgan MB: Cutaneous metastasis: a clinical, pathological, and immunohistochemical appraisal. J Cutan Pathol 2004;31:419-430.
16.
Srinivasan R, Ray R, Nijhawan R: Metastatic cutaneous and subcutaneous deposits from internal carcinomas: an analysis of cases diagnosed by fine needle aspiration. Acta Cytol 1993;37:894-898.
17.
Sharma S, Kotru M, Yadav A, Chugh M, Chawla A, Makhija M: Role of fine-needle aspiration cytology in evaluation of cutaneous metastases. Diagn Cytopathol 2009;37:876-880.
18.
Sittart JA, Senise M: Cutaneous metastasis from internal carcinomas: a review of 45 years. An Bras Dermatol 2013;88:541-544.
19.
Porter NA, Anderson HL, Al-Dujaily S: Renal cell carcinoma presenting as a solitary cutaneous facial metastasis: case report and review of the literature. Int Semin Surg Oncol 2006;3:27.
20.
Bodemer C, Dubois M, Droz D, Zucker R, de Prost Y: Congenital cutaneous metastasis of neuroblastoma. Ann Dermatol Venereol 1990;117:798-800.
21.
Biswas G, Khadwal A, Kulkarni P, Bakshi A, Nair C, Kurkure P, et al: Ewing's sarcoma with cutaneous metastasis - a rare entity: report of three cases. Indian J Dermatol Venereol Leprol 2005;71:423-425.
22.
Collier DA, Busam K, Salob S: Cutaneous metastasis of osteosarcoma. J Am Acad Dermatol 2003;49:757-760.
23.
Tomasini D, Niccoli A, Crivelli F, Scandroglio I: Cutaneous scalp metastasis as the first indication of a clinically silent retroperitoneal leiomyosarcoma and of its further relapse as metastatic widespread disease. Eur J Dermatol 2014;24:264-265.
24.
Arce FP, Pinto J, Portero I, Echevarría S, Val-Bernal JF: Cutaneous metastases as initial manifestation of dedifferentiated chondrosarcoma of bone: an autopsy case with review of the literature. J Cutan Pathol 2000;27:262-267.
25.
Perna AG, Prieto VG, Lazar AJF, Ivan D: Primary cutaneous adnexal neoplasms and their metastatic look-alikes. Pathol Case Rev 2007;12:61-69.
26.
Gupta RK, Naran S: Fine needle aspiration cytology of cutaneous and subcutaneous metastatic deposits from epithelial malignancies: an analysis of 146 cases. Acta Cytol 1999;43:126-130.
27.
Kandalaft PL, Gown AM: Practical applications in immunohistochemistry: carcinomas of unknown primary site. Arch Pathol Lab Med 2016;140:508-523.
28.
Park SY, Kim BH, Kim JH, Lee S, Kang GH: Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma. Arch Pathol Lab Med 2007;131:1561-1567.
© 2016 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2016
You do not currently have access to this content.